Physician profile
Boris Chulpayev
NPI 1518284199
$11,426.42
in general payments reported to CMS, 2019-2025
19 companies · $1,295 in 2025
The $1,295 reported for 2025 was more than what 90% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,531 · 2020: $554 · 2021: $880 · 2022: $292 · 2023: $1,932 · 2024: $942 · 2025: $1,295.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,758 · Travel and Lodging: $411.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,758.47 |
| Travel and Lodging | $410.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $3,736.59 | 2019-2020 | |
| Stryker Corporation | $2,193.20 | 2019-2025 | Surpass Evolve, Axs Vecta 71 |
| Medtronic, INC. | $1,527.28 | 2021-2025 | Linq II, Pipeline, Solitaire X |
| Microvention, INC. | $1,303.93 | 2019-2025 | Stent, Web Aneurysm Embolization System, Tubing Kit - Stroke |
| Penumbra, INC. | $958.26 | 2022-2024 | Red 72, Penumbra System, Benchmark |
| Depuy Synthes Sales INC. | $323.44 | 2021-2025 | Embotrap |
| Route 92 Medical, INC. | $204.23 | 2025 | |
| Balt USA, LLC | $192.76 | 2025 | Optima Coil System, Ballast 088 Long Sheath |
| Inspiremd LTD | $179.96 | 2025 | Cguard Prime Carotid Stent System |
| Genentech USA, INC. | $143.07 | 2019-2021 | |
| Biogen, INC. | $140.49 | 2021 | |
| Contego Medical, INC | $137.46 | 2025 | |
| Silk Road Medical, INC. | $125.16 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Abbvie INC. | $89.02 | 2024-2025 | |
| Boston Scientific Corporation | $80.45 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $31.26 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $22.06 | 2021 | |
| Medtronic USA, INC. | $20.27 | 2020 | |
| Chiesi USA, INC. | $17.53 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Boris Chulpayev listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.